Skip to main content

Table 1 Summary of the 2D audit gamma results

From: A remote EPID-based dosimetric TPS-planned audit of centers for clinical trials: outcomes and analysis of contributing factors

Gamma criteria

GPR (1 SD)

GMV (1 SD)

2%,2 mm

96.2 (5.5)%

0.37 (0.11)

3%,2 mm

98.6 (2.7)%

0.30 (0.09)

3%,3 mm

99.3 (1.9)%

0.25 (0.07)